nodes	percent_of_prediction	percent_of_DWPC	metapath
Travoprost—PTGFR—Signaling by GPCR—PPBP—coronary artery disease	0.000482	0.00177	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—KNG1—coronary artery disease	0.000473	0.00174	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—AGTR1—coronary artery disease	0.00047	0.00173	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—AVPR1A—coronary artery disease	0.000467	0.00172	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ADM2—coronary artery disease	0.000466	0.00171	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CXCL10—coronary artery disease	0.00046	0.00169	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—OPRD1—coronary artery disease	0.00046	0.00169	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CCL4—coronary artery disease	0.00046	0.00169	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—HTR2A—coronary artery disease	0.000458	0.00168	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—C3—coronary artery disease	0.000458	0.00168	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—UTS2—coronary artery disease	0.000451	0.00166	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—ADRB2—coronary artery disease	0.000446	0.00164	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—TMED2—coronary artery disease	0.000442	0.00162	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—P2RY12—coronary artery disease	0.000437	0.0016	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—PLCB3—coronary artery disease	0.000437	0.0016	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—AGT—coronary artery disease	0.000435	0.0016	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CASR—coronary artery disease	0.000432	0.00159	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—AVPR1A—coronary artery disease	0.000424	0.00156	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—BDKRB1—coronary artery disease	0.000424	0.00156	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—GNA12—coronary artery disease	0.000424	0.00156	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—RLN3—coronary artery disease	0.000421	0.00155	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—DGKZ—coronary artery disease	0.000421	0.00155	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—LRP8—coronary artery disease	0.000421	0.00155	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—coronary artery disease	0.000419	0.00154	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—ADM—coronary artery disease	0.000413	0.00151	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—UTS2—coronary artery disease	0.00041	0.0015	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—AES—coronary artery disease	0.000404	0.00148	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—EDN2—coronary artery disease	0.000404	0.00148	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—PDE4B—coronary artery disease	0.000402	0.00148	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—F2—coronary artery disease	0.000402	0.00147	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—EDN1—coronary artery disease	0.000399	0.00146	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—PLCB3—coronary artery disease	0.000397	0.00146	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—P2RY12—coronary artery disease	0.000397	0.00146	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CCL5—coronary artery disease	0.000396	0.00145	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CX3CR1—coronary artery disease	0.000393	0.00144	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CASR—coronary artery disease	0.000393	0.00144	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—HRH2—coronary artery disease	0.000389	0.00143	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—GNA12—coronary artery disease	0.000385	0.00141	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—BDKRB1—coronary artery disease	0.000385	0.00141	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CX3CL1—coronary artery disease	0.000385	0.00141	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—PPP3R1—coronary artery disease	0.000378	0.00139	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—ADM—coronary artery disease	0.000375	0.00138	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CCR3—coronary artery disease	0.000368	0.00135	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—POMC—coronary artery disease	0.000366	0.00134	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—PDE4B—coronary artery disease	0.000365	0.00134	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL2—coronary artery disease	0.000358	0.00131	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ACVR1B—coronary artery disease	0.000353	0.0013	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—RHOC—coronary artery disease	0.000353	0.0013	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—HTR2A—coronary artery disease	0.000349	0.00128	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—C3—coronary artery disease	0.000348	0.00128	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CXCL2—coronary artery disease	0.000346	0.00127	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—NEDD4—coronary artery disease	0.000343	0.00126	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—F2R—coronary artery disease	0.000342	0.00126	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PF4—coronary artery disease	0.000335	0.00123	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—RAMP2—coronary artery disease	0.000335	0.00123	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PDE3A—coronary artery disease	0.000335	0.00123	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MDK—coronary artery disease	0.000335	0.00123	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CCR3—coronary artery disease	0.000334	0.00123	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—EDNRB—coronary artery disease	0.000331	0.00122	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—AGT—coronary artery disease	0.000331	0.00122	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—RALBP1—coronary artery disease	0.000319	0.00117	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—NPY5R—coronary artery disease	0.000319	0.00117	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—F2RL1—coronary artery disease	0.000319	0.00117	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CXCL2—coronary artery disease	0.000314	0.00115	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CCL3—coronary artery disease	0.000314	0.00115	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—EDNRA—coronary artery disease	0.000313	0.00115	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—ADRB1—coronary artery disease	0.000311	0.00114	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—F2R—coronary artery disease	0.00031	0.00114	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—FZD2—coronary artery disease	0.000306	0.00112	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—UTS2R—coronary artery disease	0.000306	0.00112	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—F2—coronary artery disease	0.000306	0.00112	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—EDNRB—coronary artery disease	0.000301	0.0011	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—SFRP2—coronary artery disease	0.0003	0.0011	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—APOA4—coronary artery disease	0.000295	0.00108	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ADORA3—coronary artery disease	0.000295	0.00108	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ADORA1—coronary artery disease	0.000295	0.00108	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—BDKRB2—coronary artery disease	0.000294	0.00108	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CXCL12—coronary artery disease	0.000294	0.00108	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—PLCB1—coronary artery disease	0.000288	0.00106	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PPBP—coronary artery disease	0.000285	0.00104	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PGF—coronary artery disease	0.000285	0.00104	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—EDNRA—coronary artery disease	0.000284	0.00104	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL8—coronary artery disease	0.000283	0.00104	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—ADRB1—coronary artery disease	0.000283	0.00104	CbGpPWpGaD
Travoprost—Constipation—Perindopril—coronary artery disease	0.000282	0.000388	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Losartan—coronary artery disease	0.000282	0.000388	CcSEcCtD
Travoprost—Hypersensitivity—Valsartan—coronary artery disease	0.000282	0.000387	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—HTR7—coronary artery disease	0.000282	0.00103	CbGpPWpGaD
Travoprost—Abdominal pain—Trandolapril—coronary artery disease	0.000281	0.000387	CcSEcCtD
Travoprost—Dizziness—Ezetimibe—coronary artery disease	0.000281	0.000386	CcSEcCtD
Travoprost—Palpitations—Timolol—coronary artery disease	0.000281	0.000386	CcSEcCtD
Travoprost—Abdominal pain—Enalapril—coronary artery disease	0.00028	0.000385	CcSEcCtD
Travoprost—Feeling abnormal—Captopril—coronary artery disease	0.00028	0.000385	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—DVL1—coronary artery disease	0.00028	0.00103	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ITGA2B—coronary artery disease	0.00028	0.00103	CbGpPWpGaD
Travoprost—Rash—Fenofibrate—coronary artery disease	0.00028	0.000384	CcSEcCtD
Travoprost—Dermatitis—Fenofibrate—coronary artery disease	0.00028	0.000384	CcSEcCtD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—coronary artery disease	0.000279	0.00103	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—POMC—coronary artery disease	0.000279	0.00102	CbGpPWpGaD
Travoprost—Headache—Fenofibrate—coronary artery disease	0.000278	0.000382	CcSEcCtD
Travoprost—Vision blurred—Lisinopril—coronary artery disease	0.000278	0.000382	CcSEcCtD
Travoprost—Gastrointestinal pain—Captopril—coronary artery disease	0.000278	0.000382	CcSEcCtD
Travoprost—Cough—Timolol—coronary artery disease	0.000277	0.000381	CcSEcCtD
Travoprost—Diarrhoea—Simvastatin—coronary artery disease	0.000277	0.000381	CcSEcCtD
Travoprost—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000277	0.000381	CcSEcCtD
Travoprost—Arthralgia—Ramipril—coronary artery disease	0.000277	0.00038	CcSEcCtD
Travoprost—Chest pain—Ramipril—coronary artery disease	0.000277	0.00038	CcSEcCtD
Travoprost—Myalgia—Ramipril—coronary artery disease	0.000277	0.00038	CcSEcCtD
Travoprost—Fatigue—Furosemide—coronary artery disease	0.000277	0.00038	CcSEcCtD
Travoprost—Abdominal pain—Telmisartan—coronary artery disease	0.000276	0.00038	CcSEcCtD
Travoprost—Dyspnoea—Losartan—coronary artery disease	0.000276	0.000379	CcSEcCtD
Travoprost—Anxiety—Ramipril—coronary artery disease	0.000276	0.000379	CcSEcCtD
Travoprost—Dizziness—Eplerenone—coronary artery disease	0.000275	0.000378	CcSEcCtD
Travoprost—Rash—Clopidogrel—coronary artery disease	0.000275	0.000378	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	0.000275	0.000378	CcSEcCtD
Travoprost—Dermatitis—Clopidogrel—coronary artery disease	0.000275	0.000378	CcSEcCtD
Travoprost—Asthenia—Valsartan—coronary artery disease	0.000275	0.000377	CcSEcCtD
Travoprost—Hypertension—Timolol—coronary artery disease	0.000274	0.000377	CcSEcCtD
Travoprost—Pain—Furosemide—coronary artery disease	0.000274	0.000377	CcSEcCtD
Travoprost—Constipation—Furosemide—coronary artery disease	0.000274	0.000377	CcSEcCtD
Travoprost—Hypersensitivity—Niacin—coronary artery disease	0.000274	0.000377	CcSEcCtD
Travoprost—Ill-defined disorder—Lisinopril—coronary artery disease	0.000274	0.000376	CcSEcCtD
Travoprost—Discomfort—Ramipril—coronary artery disease	0.000274	0.000376	CcSEcCtD
Travoprost—Asthenia—Olmesartan—coronary artery disease	0.000273	0.000376	CcSEcCtD
Travoprost—Headache—Clopidogrel—coronary artery disease	0.000273	0.000375	CcSEcCtD
Travoprost—Rash—Lovastatin—coronary artery disease	0.000273	0.000375	CcSEcCtD
Travoprost—Dermatitis—Lovastatin—coronary artery disease	0.000273	0.000375	CcSEcCtD
Travoprost—PTGFR—GPCR ligand binding—CCL2—coronary artery disease	0.000273	0.001	CbGpPWpGaD
Travoprost—Dyspepsia—Losartan—coronary artery disease	0.000272	0.000374	CcSEcCtD
Travoprost—Feeling abnormal—Perindopril—coronary artery disease	0.000272	0.000374	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—CCL4—coronary artery disease	0.000271	0.000997	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—OPRD1—coronary artery disease	0.000271	0.000997	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—GHR—coronary artery disease	0.000271	0.000997	CbGpPWpGaD
Travoprost—Headache—Lovastatin—coronary artery disease	0.000271	0.000373	CcSEcCtD
Travoprost—PTGFR—G alpha (q) signalling events—PIK3CA—coronary artery disease	0.000271	0.000996	CbGpPWpGaD
Travoprost—Pruritus—Valsartan—coronary artery disease	0.000271	0.000372	CcSEcCtD
Travoprost—Dry mouth—Ramipril—coronary artery disease	0.000271	0.000372	CcSEcCtD
Travoprost—Myalgia—Timolol—coronary artery disease	0.000271	0.000372	CcSEcCtD
Travoprost—Chest pain—Timolol—coronary artery disease	0.000271	0.000372	CcSEcCtD
Travoprost—Arthralgia—Timolol—coronary artery disease	0.000271	0.000372	CcSEcCtD
Travoprost—Hypersensitivity—Pravastatin—coronary artery disease	0.00027	0.000371	CcSEcCtD
Travoprost—Gastrointestinal pain—Perindopril—coronary artery disease	0.00027	0.000371	CcSEcCtD
Travoprost—Anxiety—Timolol—coronary artery disease	0.00027	0.000371	CcSEcCtD
Travoprost—Pruritus—Olmesartan—coronary artery disease	0.000269	0.00037	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	0.000269	0.000369	CcSEcCtD
Travoprost—Abdominal pain—Captopril—coronary artery disease	0.000269	0.000369	CcSEcCtD
Travoprost—Dizziness—Simvastatin—coronary artery disease	0.000268	0.000368	CcSEcCtD
Travoprost—Rash—Ezetimibe—coronary artery disease	0.000268	0.000368	CcSEcCtD
Travoprost—Dermatitis—Ezetimibe—coronary artery disease	0.000268	0.000368	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—KNG1—coronary artery disease	0.000267	0.000982	CbGpPWpGaD
Travoprost—Discomfort—Timolol—coronary artery disease	0.000267	0.000367	CcSEcCtD
Travoprost—Asthenia—Niacin—coronary artery disease	0.000267	0.000367	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—BDKRB2—coronary artery disease	0.000267	0.00098	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CXCL12—coronary artery disease	0.000267	0.00098	CbGpPWpGaD
Travoprost—Fatigue—Losartan—coronary artery disease	0.000267	0.000367	CcSEcCtD
Travoprost—Headache—Ezetimibe—coronary artery disease	0.000266	0.000366	CcSEcCtD
Travoprost—Malaise—Lisinopril—coronary artery disease	0.000266	0.000365	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—AGTR1—coronary artery disease	0.000266	0.000976	CbGpPWpGaD
Travoprost—Oedema—Ramipril—coronary artery disease	0.000265	0.000365	CcSEcCtD
Travoprost—Vertigo—Lisinopril—coronary artery disease	0.000265	0.000364	CcSEcCtD
Travoprost—Dry mouth—Timolol—coronary artery disease	0.000265	0.000364	CcSEcCtD
Travoprost—Constipation—Losartan—coronary artery disease	0.000265	0.000364	CcSEcCtD
Travoprost—Pain—Losartan—coronary artery disease	0.000265	0.000364	CcSEcCtD
Travoprost—Feeling abnormal—Furosemide—coronary artery disease	0.000264	0.000363	CcSEcCtD
Travoprost—Nausea—Fenofibrate—coronary artery disease	0.000264	0.000362	CcSEcCtD
Travoprost—Pruritus—Niacin—coronary artery disease	0.000263	0.000362	CcSEcCtD
Travoprost—Asthenia—Pravastatin—coronary artery disease	0.000263	0.000361	CcSEcCtD
Travoprost—Gastrointestinal pain—Furosemide—coronary artery disease	0.000262	0.00036	CcSEcCtD
Travoprost—Rash—Eplerenone—coronary artery disease	0.000262	0.00036	CcSEcCtD
Travoprost—Hypersensitivity—Trandolapril—coronary artery disease	0.000262	0.00036	CcSEcCtD
Travoprost—Dermatitis—Eplerenone—coronary artery disease	0.000262	0.00036	CcSEcCtD
Travoprost—Diarrhoea—Valsartan—coronary artery disease	0.000262	0.00036	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—PLCB1—coronary artery disease	0.000261	0.000959	CbGpPWpGaD
Travoprost—Hypersensitivity—Enalapril—coronary artery disease	0.000261	0.000359	CcSEcCtD
Travoprost—Abdominal pain—Perindopril—coronary artery disease	0.000261	0.000358	CcSEcCtD
Travoprost—Palpitations—Lisinopril—coronary artery disease	0.000261	0.000358	CcSEcCtD
Travoprost—Diarrhoea—Olmesartan—coronary artery disease	0.000261	0.000358	CcSEcCtD
Travoprost—Headache—Eplerenone—coronary artery disease	0.000261	0.000358	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—TLE4—coronary artery disease	0.00026	0.000956	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MEF2A—coronary artery disease	0.00026	0.000956	CbGpPWpGaD
Travoprost—Nervous system disorder—Ramipril—coronary artery disease	0.00026	0.000358	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—CXCL10—coronary artery disease	0.00026	0.000954	CbGpPWpGaD
Travoprost—Oedema—Timolol—coronary artery disease	0.000259	0.000357	CcSEcCtD
Travoprost—Pruritus—Pravastatin—coronary artery disease	0.000259	0.000356	CcSEcCtD
Travoprost—Nausea—Clopidogrel—coronary artery disease	0.000259	0.000356	CcSEcCtD
Travoprost—Tachycardia—Ramipril—coronary artery disease	0.000259	0.000356	CcSEcCtD
Travoprost—Skin disorder—Ramipril—coronary artery disease	0.000258	0.000354	CcSEcCtD
Travoprost—Infection—Timolol—coronary artery disease	0.000258	0.000354	CcSEcCtD
Travoprost—Hypersensitivity—Telmisartan—coronary artery disease	0.000258	0.000354	CcSEcCtD
Travoprost—Cough—Lisinopril—coronary artery disease	0.000257	0.000354	CcSEcCtD
Travoprost—Nausea—Lovastatin—coronary artery disease	0.000257	0.000354	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—HTR7—coronary artery disease	0.000256	0.000939	CbGpPWpGaD
Travoprost—Rash—Simvastatin—coronary artery disease	0.000256	0.000351	CcSEcCtD
Travoprost—Dermatitis—Simvastatin—coronary artery disease	0.000255	0.000351	CcSEcCtD
Travoprost—Asthenia—Trandolapril—coronary artery disease	0.000255	0.000351	CcSEcCtD
Travoprost—Feeling abnormal—Losartan—coronary artery disease	0.000255	0.000351	CcSEcCtD
Travoprost—Diarrhoea—Niacin—coronary artery disease	0.000255	0.00035	CcSEcCtD
Travoprost—Nervous system disorder—Timolol—coronary artery disease	0.000254	0.00035	CcSEcCtD
Travoprost—Asthenia—Enalapril—coronary artery disease	0.000254	0.000349	CcSEcCtD
Travoprost—Headache—Simvastatin—coronary artery disease	0.000254	0.000349	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—APOA2—coronary artery disease	0.000254	0.000931	CbGpPWpGaD
Travoprost—Abdominal pain—Furosemide—coronary artery disease	0.000254	0.000348	CcSEcCtD
Travoprost—Gastrointestinal pain—Losartan—coronary artery disease	0.000253	0.000348	CcSEcCtD
Travoprost—Dizziness—Valsartan—coronary artery disease	0.000253	0.000348	CcSEcCtD
Travoprost—Nausea—Ezetimibe—coronary artery disease	0.000252	0.000347	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—ADRB2—coronary artery disease	0.000252	0.000926	CbGpPWpGaD
Travoprost—Skin disorder—Timolol—coronary artery disease	0.000252	0.000346	CcSEcCtD
Travoprost—Dizziness—Olmesartan—coronary artery disease	0.000252	0.000346	CcSEcCtD
Travoprost—Pruritus—Trandolapril—coronary artery disease	0.000252	0.000346	CcSEcCtD
Travoprost—Myalgia—Lisinopril—coronary artery disease	0.000251	0.000345	CcSEcCtD
Travoprost—Chest pain—Lisinopril—coronary artery disease	0.000251	0.000345	CcSEcCtD
Travoprost—Arthralgia—Lisinopril—coronary artery disease	0.000251	0.000345	CcSEcCtD
Travoprost—Asthenia—Telmisartan—coronary artery disease	0.000251	0.000345	CcSEcCtD
Travoprost—Pruritus—Enalapril—coronary artery disease	0.000251	0.000345	CcSEcCtD
Travoprost—Diarrhoea—Pravastatin—coronary artery disease	0.000251	0.000344	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—AVPR1A—coronary artery disease	0.000251	0.00092	CbGpPWpGaD
Travoprost—Anxiety—Lisinopril—coronary artery disease	0.00025	0.000344	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.000249	0.000343	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—PRKCE—coronary artery disease	0.000249	0.000914	CbGpPWpGaD
Travoprost—Discomfort—Lisinopril—coronary artery disease	0.000248	0.000341	CcSEcCtD
Travoprost—Hypotension—Ramipril—coronary artery disease	0.000248	0.000341	CcSEcCtD
Travoprost—Pruritus—Telmisartan—coronary artery disease	0.000247	0.00034	CcSEcCtD
Travoprost—Nausea—Eplerenone—coronary artery disease	0.000247	0.00034	CcSEcCtD
Travoprost—Dizziness—Niacin—coronary artery disease	0.000246	0.000338	CcSEcCtD
Travoprost—Dry mouth—Lisinopril—coronary artery disease	0.000246	0.000337	CcSEcCtD
Travoprost—Abdominal pain—Losartan—coronary artery disease	0.000245	0.000336	CcSEcCtD
Travoprost—Asthenia—Captopril—coronary artery disease	0.000244	0.000335	CcSEcCtD
Travoprost—Diarrhoea—Trandolapril—coronary artery disease	0.000243	0.000335	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—KNG1—coronary artery disease	0.000243	0.000892	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—coronary artery disease	0.000242	0.00089	CbGpPWpGaD
Travoprost—Diarrhoea—Enalapril—coronary artery disease	0.000242	0.000333	CcSEcCtD
Travoprost—Hypotension—Timolol—coronary artery disease	0.000242	0.000333	CcSEcCtD
Travoprost—Dizziness—Pravastatin—coronary artery disease	0.000242	0.000333	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—UTS2—coronary artery disease	0.000242	0.000889	CbGpPWpGaD
Travoprost—Musculoskeletal discomfort—Ramipril—coronary artery disease	0.000242	0.000332	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—AGTR1—coronary artery disease	0.000241	0.000886	CbGpPWpGaD
Travoprost—Rash—Valsartan—coronary artery disease	0.000241	0.000332	CcSEcCtD
Travoprost—Dermatitis—Valsartan—coronary artery disease	0.000241	0.000331	CcSEcCtD
Travoprost—Nausea—Simvastatin—coronary artery disease	0.000241	0.000331	CcSEcCtD
Travoprost—Oedema—Lisinopril—coronary artery disease	0.000241	0.000331	CcSEcCtD
Travoprost—Pruritus—Captopril—coronary artery disease	0.00024	0.00033	CcSEcCtD
Travoprost—Rash—Olmesartan—coronary artery disease	0.00024	0.00033	CcSEcCtD
Travoprost—Dermatitis—Olmesartan—coronary artery disease	0.00024	0.00033	CcSEcCtD
Travoprost—Headache—Valsartan—coronary artery disease	0.00024	0.000329	CcSEcCtD
Travoprost—Diarrhoea—Telmisartan—coronary artery disease	0.000239	0.000329	CcSEcCtD
Travoprost—Infection—Lisinopril—coronary artery disease	0.000239	0.000329	CcSEcCtD
Travoprost—Headache—Olmesartan—coronary artery disease	0.000239	0.000328	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—NR4A1—coronary artery disease	0.000237	0.00087	CbGpPWpGaD
Travoprost—Asthenia—Perindopril—coronary artery disease	0.000237	0.000325	CcSEcCtD
Travoprost—Dyspnoea—Ramipril—coronary artery disease	0.000237	0.000325	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Timolol—coronary artery disease	0.000236	0.000325	CcSEcCtD
Travoprost—Hypersensitivity—Furosemide—coronary artery disease	0.000236	0.000325	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—CXCL10—coronary artery disease	0.000236	0.000866	CbGpPWpGaD
Travoprost—Dizziness—Trandolapril—coronary artery disease	0.000235	0.000323	CcSEcCtD
Travoprost—Tachycardia—Lisinopril—coronary artery disease	0.000235	0.000323	CcSEcCtD
Travoprost—Rash—Niacin—coronary artery disease	0.000235	0.000322	CcSEcCtD
Travoprost—Dermatitis—Niacin—coronary artery disease	0.000234	0.000322	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—PLCB3—coronary artery disease	0.000234	0.000861	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—HDAC9—coronary artery disease	0.000234	0.000861	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—P2RY12—coronary artery disease	0.000234	0.000861	CbGpPWpGaD
Travoprost—Dizziness—Enalapril—coronary artery disease	0.000234	0.000322	CcSEcCtD
Travoprost—Skin disorder—Lisinopril—coronary artery disease	0.000234	0.000321	CcSEcCtD
Travoprost—Dyspepsia—Ramipril—coronary artery disease	0.000234	0.000321	CcSEcCtD
Travoprost—Pruritus—Perindopril—coronary artery disease	0.000233	0.000321	CcSEcCtD
Travoprost—Headache—Niacin—coronary artery disease	0.000233	0.00032	CcSEcCtD
Travoprost—Diarrhoea—Captopril—coronary artery disease	0.000233	0.00032	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—CX3CR1—coronary artery disease	0.000232	0.000852	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CASR—coronary artery disease	0.000232	0.000852	CbGpPWpGaD
Travoprost—Dyspnoea—Timolol—coronary artery disease	0.000231	0.000318	CcSEcCtD
Travoprost—Dizziness—Telmisartan—coronary artery disease	0.000231	0.000318	CcSEcCtD
Travoprost—Rash—Pravastatin—coronary artery disease	0.000231	0.000317	CcSEcCtD
Travoprost—Dermatitis—Pravastatin—coronary artery disease	0.000231	0.000317	CcSEcCtD
Travoprost—Asthenia—Furosemide—coronary artery disease	0.00023	0.000316	CcSEcCtD
Travoprost—Headache—Pravastatin—coronary artery disease	0.00023	0.000315	CcSEcCtD
Travoprost—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000229	0.000315	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—ADRB2—coronary artery disease	0.000229	0.000841	CbGpPWpGaD
Travoprost—Fatigue—Ramipril—coronary artery disease	0.000229	0.000314	CcSEcCtD
Travoprost—Dyspepsia—Timolol—coronary artery disease	0.000228	0.000314	CcSEcCtD
Travoprost—Hypersensitivity—Losartan—coronary artery disease	0.000228	0.000313	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—BDKRB1—coronary artery disease	0.000228	0.000835	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—GNA12—coronary artery disease	0.000228	0.000835	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—P4HB—coronary artery disease	0.000228	0.000835	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CX3CL1—coronary artery disease	0.000228	0.000835	CbGpPWpGaD
Travoprost—Nausea—Valsartan—coronary artery disease	0.000227	0.000312	CcSEcCtD
Travoprost—Pruritus—Furosemide—coronary artery disease	0.000227	0.000312	CcSEcCtD
Travoprost—Constipation—Ramipril—coronary artery disease	0.000227	0.000312	CcSEcCtD
Travoprost—Nausea—Olmesartan—coronary artery disease	0.000226	0.000311	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—PRKCE—coronary artery disease	0.000226	0.00083	CbGpPWpGaD
Travoprost—Diarrhoea—Perindopril—coronary artery disease	0.000226	0.00031	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—EDN1—coronary artery disease	0.000225	0.000828	CbGpPWpGaD
Travoprost—Hypotension—Lisinopril—coronary artery disease	0.000225	0.000309	CcSEcCtD
Travoprost—Dizziness—Captopril—coronary artery disease	0.000225	0.000309	CcSEcCtD
Travoprost—Rash—Trandolapril—coronary artery disease	0.000224	0.000308	CcSEcCtD
Travoprost—Dermatitis—Trandolapril—coronary artery disease	0.000224	0.000308	CcSEcCtD
Travoprost—Gastrointestinal disorder—Timolol—coronary artery disease	0.000224	0.000308	CcSEcCtD
Travoprost—Fatigue—Timolol—coronary artery disease	0.000224	0.000307	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—CCL5—coronary artery disease	0.000224	0.000821	CbGpPWpGaD
Travoprost—Rash—Enalapril—coronary artery disease	0.000223	0.000307	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—PPP3R1—coronary artery disease	0.000223	0.00082	CbGpPWpGaD
Travoprost—Dermatitis—Enalapril—coronary artery disease	0.000223	0.000307	CcSEcCtD
Travoprost—Headache—Trandolapril—coronary artery disease	0.000223	0.000306	CcSEcCtD
Travoprost—Asthenia—Losartan—coronary artery disease	0.000222	0.000305	CcSEcCtD
Travoprost—Headache—Enalapril—coronary artery disease	0.000222	0.000305	CcSEcCtD
Travoprost—Pain—Timolol—coronary artery disease	0.000222	0.000305	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—ADM—coronary artery disease	0.000221	0.000813	CbGpPWpGaD
Travoprost—Nausea—Niacin—coronary artery disease	0.000221	0.000304	CcSEcCtD
Travoprost—Rash—Telmisartan—coronary artery disease	0.00022	0.000303	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—CSF2—coronary artery disease	0.00022	0.000809	CbGpPWpGaD
Travoprost—Dermatitis—Telmisartan—coronary artery disease	0.00022	0.000303	CcSEcCtD
Travoprost—Diarrhoea—Furosemide—coronary artery disease	0.000219	0.000302	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Lisinopril—coronary artery disease	0.000219	0.000301	CcSEcCtD
Travoprost—Pruritus—Losartan—coronary artery disease	0.000219	0.000301	CcSEcCtD
Travoprost—Headache—Telmisartan—coronary artery disease	0.000219	0.000301	CcSEcCtD
Travoprost—Feeling abnormal—Ramipril—coronary artery disease	0.000219	0.000301	CcSEcCtD
Travoprost—Dizziness—Perindopril—coronary artery disease	0.000218	0.0003	CcSEcCtD
Travoprost—Nausea—Pravastatin—coronary artery disease	0.000218	0.000299	CcSEcCtD
Travoprost—Gastrointestinal pain—Ramipril—coronary artery disease	0.000217	0.000298	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—PDE4B—coronary artery disease	0.000216	0.000792	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CYBB—coronary artery disease	0.000216	0.000792	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CXCL8—coronary artery disease	0.000216	0.000791	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—MMP3—coronary artery disease	0.000215	0.00079	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—coronary artery disease	0.000215	0.000788	CbGpPWpGaD
Travoprost—Dyspnoea—Lisinopril—coronary artery disease	0.000215	0.000295	CcSEcCtD
Travoprost—Rash—Captopril—coronary artery disease	0.000214	0.000294	CcSEcCtD
Travoprost—Dermatitis—Captopril—coronary artery disease	0.000214	0.000294	CcSEcCtD
Travoprost—Feeling abnormal—Timolol—coronary artery disease	0.000214	0.000294	CcSEcCtD
Travoprost—Headache—Captopril—coronary artery disease	0.000213	0.000293	CcSEcCtD
Travoprost—Gastrointestinal pain—Timolol—coronary artery disease	0.000212	0.000292	CcSEcCtD
Travoprost—Dizziness—Furosemide—coronary artery disease	0.000212	0.000292	CcSEcCtD
Travoprost—Dyspepsia—Lisinopril—coronary artery disease	0.000212	0.000291	CcSEcCtD
Travoprost—Diarrhoea—Losartan—coronary artery disease	0.000212	0.000291	CcSEcCtD
Travoprost—Nausea—Trandolapril—coronary artery disease	0.000211	0.00029	CcSEcCtD
Travoprost—Nausea—Enalapril—coronary artery disease	0.00021	0.000289	CcSEcCtD
Travoprost—Abdominal pain—Ramipril—coronary artery disease	0.00021	0.000288	CcSEcCtD
Travoprost—Rash—Perindopril—coronary artery disease	0.000208	0.000286	CcSEcCtD
Travoprost—Dermatitis—Perindopril—coronary artery disease	0.000208	0.000286	CcSEcCtD
Travoprost—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000208	0.000286	CcSEcCtD
Travoprost—Nausea—Telmisartan—coronary artery disease	0.000208	0.000285	CcSEcCtD
Travoprost—Fatigue—Lisinopril—coronary artery disease	0.000208	0.000285	CcSEcCtD
Travoprost—Headache—Perindopril—coronary artery disease	0.000207	0.000284	CcSEcCtD
Travoprost—Constipation—Lisinopril—coronary artery disease	0.000206	0.000283	CcSEcCtD
Travoprost—Pain—Lisinopril—coronary artery disease	0.000206	0.000283	CcSEcCtD
Travoprost—Abdominal pain—Timolol—coronary artery disease	0.000205	0.000282	CcSEcCtD
Travoprost—Dizziness—Losartan—coronary artery disease	0.000205	0.000281	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—EDN1—coronary artery disease	0.000205	0.000752	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CCL5—coronary artery disease	0.000203	0.000746	CbGpPWpGaD
Travoprost—Rash—Furosemide—coronary artery disease	0.000202	0.000278	CcSEcCtD
Travoprost—Dermatitis—Furosemide—coronary artery disease	0.000202	0.000278	CcSEcCtD
Travoprost—Nausea—Captopril—coronary artery disease	0.000202	0.000277	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—PRKCD—coronary artery disease	0.000201	0.00074	CbGpPWpGaD
Travoprost—Headache—Furosemide—coronary artery disease	0.000201	0.000276	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—CSF2—coronary artery disease	0.0002	0.000735	CbGpPWpGaD
Travoprost—Feeling abnormal—Lisinopril—coronary artery disease	0.000198	0.000273	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—CCR3—coronary artery disease	0.000197	0.000724	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—HTR2A—coronary artery disease	0.000197	0.000724	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—C3—coronary artery disease	0.000197	0.000723	CbGpPWpGaD
Travoprost—Gastrointestinal pain—Lisinopril—coronary artery disease	0.000197	0.00027	CcSEcCtD
Travoprost—Nausea—Perindopril—coronary artery disease	0.000196	0.000269	CcSEcCtD
Travoprost—Hypersensitivity—Ramipril—coronary artery disease	0.000196	0.000269	CcSEcCtD
Travoprost—Rash—Losartan—coronary artery disease	0.000195	0.000268	CcSEcCtD
Travoprost—Dermatitis—Losartan—coronary artery disease	0.000195	0.000268	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—CRK—coronary artery disease	0.000195	0.000715	CbGpPWpGaD
Travoprost—Headache—Losartan—coronary artery disease	0.000194	0.000266	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—SH2B3—coronary artery disease	0.000192	0.000706	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ATP2A2—coronary artery disease	0.000192	0.000706	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—VWF—coronary artery disease	0.000192	0.000706	CbGpPWpGaD
Travoprost—Hypersensitivity—Timolol—coronary artery disease	0.000191	0.000263	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—APOC3—coronary artery disease	0.000191	0.000702	CbGpPWpGaD
Travoprost—Nausea—Furosemide—coronary artery disease	0.000191	0.000262	CcSEcCtD
Travoprost—Asthenia—Ramipril—coronary artery disease	0.00019	0.000262	CcSEcCtD
Travoprost—Abdominal pain—Lisinopril—coronary artery disease	0.00019	0.000261	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—LDLR—coronary artery disease	0.00019	0.000697	CbGpPWpGaD
Travoprost—Pruritus—Ramipril—coronary artery disease	0.000188	0.000258	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—AGT—coronary artery disease	0.000187	0.000687	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—PPP2CA—coronary artery disease	0.000186	0.000684	CbGpPWpGaD
Travoprost—Asthenia—Timolol—coronary artery disease	0.000186	0.000256	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—CCL3—coronary artery disease	0.000185	0.000681	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CXCL2—coronary artery disease	0.000185	0.000681	CbGpPWpGaD
Travoprost—Nausea—Losartan—coronary artery disease	0.000184	0.000253	CcSEcCtD
Travoprost—Pruritus—Timolol—coronary artery disease	0.000184	0.000252	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—SDC1—coronary artery disease	0.000183	0.000673	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—F2R—coronary artery disease	0.000183	0.000673	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—PRKCD—coronary artery disease	0.000183	0.000672	CbGpPWpGaD
Travoprost—Diarrhoea—Ramipril—coronary artery disease	0.000182	0.00025	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—FGB—coronary artery disease	0.000179	0.000659	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—HTR2A—coronary artery disease	0.000179	0.000657	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—C3—coronary artery disease	0.000179	0.000657	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—EDNRB—coronary artery disease	0.000178	0.000652	CbGpPWpGaD
Travoprost—Diarrhoea—Timolol—coronary artery disease	0.000178	0.000244	CcSEcCtD
Travoprost—Hypersensitivity—Lisinopril—coronary artery disease	0.000177	0.000244	CcSEcCtD
Travoprost—Dizziness—Ramipril—coronary artery disease	0.000176	0.000241	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—THBS1—coronary artery disease	0.000175	0.000642	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PSMA6—coronary artery disease	0.000173	0.000636	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PSMB5—coronary artery disease	0.000173	0.000636	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—F2—coronary artery disease	0.000173	0.000635	CbGpPWpGaD
Travoprost—Asthenia—Lisinopril—coronary artery disease	0.000173	0.000237	CcSEcCtD
Travoprost—Dizziness—Timolol—coronary artery disease	0.000172	0.000236	CcSEcCtD
Travoprost—Pruritus—Lisinopril—coronary artery disease	0.00017	0.000234	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—AGT—coronary artery disease	0.00017	0.000624	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—EDNRA—coronary artery disease	0.000168	0.000616	CbGpPWpGaD
Travoprost—Rash—Ramipril—coronary artery disease	0.000167	0.00023	CcSEcCtD
Travoprost—Dermatitis—Ramipril—coronary artery disease	0.000167	0.00023	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—CYBA—coronary artery disease	0.000167	0.000613	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ADRB1—coronary artery disease	0.000167	0.000613	CbGpPWpGaD
Travoprost—Headache—Ramipril—coronary artery disease	0.000166	0.000228	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—DUSP6—coronary artery disease	0.000166	0.00061	CbGpPWpGaD
Travoprost—Diarrhoea—Lisinopril—coronary artery disease	0.000165	0.000226	CcSEcCtD
Travoprost—Rash—Timolol—coronary artery disease	0.000164	0.000225	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—PLAT—coronary artery disease	0.000163	0.0006	CbGpPWpGaD
Travoprost—Dermatitis—Timolol—coronary artery disease	0.000163	0.000225	CcSEcCtD
Travoprost—Headache—Timolol—coronary artery disease	0.000163	0.000223	CcSEcCtD
Travoprost—Dizziness—Lisinopril—coronary artery disease	0.000159	0.000219	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—CXCL12—coronary artery disease	0.000158	0.000579	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—BDKRB2—coronary artery disease	0.000158	0.000579	CbGpPWpGaD
Travoprost—Nausea—Ramipril—coronary artery disease	0.000158	0.000217	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—POMC—coronary artery disease	0.000157	0.000578	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—F2—coronary artery disease	0.000157	0.000576	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—IL6ST—coronary artery disease	0.000156	0.000574	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—JUNB—coronary artery disease	0.000155	0.000568	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PLCB1—coronary artery disease	0.000154	0.000566	CbGpPWpGaD
Travoprost—Nausea—Timolol—coronary artery disease	0.000154	0.000212	CcSEcCtD
Travoprost—Rash—Lisinopril—coronary artery disease	0.000152	0.000209	CcSEcCtD
Travoprost—Dermatitis—Lisinopril—coronary artery disease	0.000152	0.000208	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—HTR7—coronary artery disease	0.000151	0.000555	CbGpPWpGaD
Travoprost—Headache—Lisinopril—coronary artery disease	0.000151	0.000207	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—ITGAV—coronary artery disease	0.000144	0.000528	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—KNG1—coronary artery disease	0.000143	0.000527	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—POMC—coronary artery disease	0.000143	0.000525	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CREB1—coronary artery disease	0.000143	0.000525	CbGpPWpGaD
Travoprost—Nausea—Lisinopril—coronary artery disease	0.000143	0.000196	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—AGTR1—coronary artery disease	0.000143	0.000524	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CCL2—coronary artery disease	0.00014	0.000514	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—IL6R—coronary artery disease	0.000139	0.000512	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CXCL10—coronary artery disease	0.000139	0.000512	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PLG—coronary artery disease	0.000139	0.00051	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ADRB2—coronary artery disease	0.000135	0.000497	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PRKCE—coronary artery disease	0.000134	0.000491	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—JAK2—coronary artery disease	0.000133	0.00049	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—SOCS1—coronary artery disease	0.000133	0.000489	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—S100B—coronary artery disease	0.000133	0.000488	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—SOCS3—coronary artery disease	0.000132	0.000483	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—KITLG—coronary artery disease	0.00013	0.000478	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—TGFBR2—coronary artery disease	0.00013	0.000478	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—STAT5A—coronary artery disease	0.000127	0.000467	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MMP3—coronary artery disease	0.000127	0.000467	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—APOB—coronary artery disease	0.000123	0.000451	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CXCL8—coronary artery disease	0.000122	0.000447	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—JAK2—coronary artery disease	0.000121	0.000445	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—EDN1—coronary artery disease	0.000121	0.000444	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CCL5—coronary artery disease	0.00012	0.000441	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CSF2—coronary artery disease	0.000118	0.000434	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—FGF1—coronary artery disease	0.000118	0.000434	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—LPL—coronary artery disease	0.000117	0.000431	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—RPS6KB1—coronary artery disease	0.000116	0.000427	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MEF2C—coronary artery disease	0.000116	0.000427	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ITGB3—coronary artery disease	0.000113	0.000416	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CXCL8—coronary artery disease	0.000111	0.000406	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PPP2CA—coronary artery disease	0.00011	0.000404	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PRKCD—coronary artery disease	0.000108	0.000397	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—HTR2A—coronary artery disease	0.000106	0.000388	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—C3—coronary artery disease	0.000106	0.000388	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—HIF1A—coronary artery disease	0.000101	0.00037	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—AGT—coronary artery disease	0.0001	0.000369	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—APOE—coronary artery disease	9.83e-05	0.000361	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—LEP—coronary artery disease	9.83e-05	0.000361	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—APOA1—coronary artery disease	9.72e-05	0.000357	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—KDR—coronary artery disease	9.63e-05	0.000354	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MAPK14—coronary artery disease	9.57e-05	0.000351	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ESR1—coronary artery disease	9.39e-05	0.000345	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—F2—coronary artery disease	9.27e-05	0.000341	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—FN1—coronary artery disease	9.27e-05	0.000341	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—IL6ST—coronary artery disease	9.24e-05	0.000339	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—NFKBIA—coronary artery disease	9.16e-05	0.000336	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—KIT—coronary artery disease	8.87e-05	0.000326	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—GSK3B—coronary artery disease	8.52e-05	0.000313	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—POMC—coronary artery disease	8.45e-05	0.00031	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CREB1—coronary artery disease	8.45e-05	0.00031	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CCL2—coronary artery disease	8.26e-05	0.000303	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—IL6R—coronary artery disease	8.24e-05	0.000303	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—IGF1—coronary artery disease	8.13e-05	0.000298	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—MAPK1—coronary artery disease	8.09e-05	0.000297	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—PIK3CA—coronary artery disease	7.73e-05	0.000284	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—SERPINE1—coronary artery disease	7.72e-05	0.000283	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—FGF2—coronary artery disease	7.47e-05	0.000274	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—NOS3—coronary artery disease	7.37e-05	0.000271	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—JAK2—coronary artery disease	7.16e-05	0.000263	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—PIK3CA—coronary artery disease	7.02e-05	0.000258	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CXCL8—coronary artery disease	6.53e-05	0.00024	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—AKT1—coronary artery disease	6.31e-05	0.000232	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CASP3—coronary artery disease	6.25e-05	0.00023	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—IL6—coronary artery disease	6.21e-05	0.000228	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CCND1—coronary artery disease	6.09e-05	0.000224	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MMP9—coronary artery disease	5.91e-05	0.000217	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—AKT1—coronary artery disease	5.73e-05	0.00021	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—VEGFA—coronary artery disease	5.31e-05	0.000195	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—TGFB1—coronary artery disease	4.87e-05	0.000179	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MAPK1—coronary artery disease	4.78e-05	0.000175	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PIK3CA—coronary artery disease	4.15e-05	0.000152	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—IL6—coronary artery disease	3.67e-05	0.000135	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—AKT1—coronary artery disease	3.39e-05	0.000124	CbGpPWpGaD
